New and Generic Drug Approvals (Jul 29):
*ANAPROX (naproxen sodium) Tablets, Hoffmann-La Roche, Inc., Labeling Revision *ANAPROX DS (naproxen sodium) Tablets, Hoffmann-La Roche, Inc., Labeling Revision *EC-NAPROSYN (naproxen) Delayed-Release Tablets, Hoffmann-La Roche, Inc., Labeling Revision *LOPRESSOR HCT (hydrochlorothiazide and metoprolol tartrate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision *NAPROXYN (naproxen) Tablets, Hoffmann-La Roche, Inc., Labeling Revision *NAPROSYN (naproxen) Oral Suspension, Hoffmann-La Roche, Inc., Labeling Revision *Pamidronate Disodium Injection, PharmaForce, Inc., Approval 

New and Generic Drug Approvals (Jul 28)
*CAPASTAT SULFATE (capreomycin sulfate) Injection, Eli Lilly and Co., Labeling Revision *Ceftriaxone (ceftriaxone sodium) Injection, ACS Dobfar, SPA, Approval *Ceftriaxone (ceftriaxone sodium) Injection, ACS Dobfar, SPA, Approval *ELMIRON (pentosan polysulfate sodium) Capsules, Johnson & Johnson Pharmaceutical Research & Development, LLC, Labeling Revision *LOPRESSOR (metoprolol tartrate) Injection, Novartis Pharmaceuticals Corp., Labeling Revision *LOPRESSOR (metoprolol tartrate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision *Nicardipine Hydrochloride Injection, Teva Parenteral Medicines, Approval 


Zynchos Pharmacy Services